Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Lilly develops assay for antitumor agent of natural origin

May 13, 1998

Novartis seek patients for phase III trials of PSC-833

May 13, 1998

XR-9576 enters clinical testing

May 12, 1998

Zadaxin decreases formation of lung tumors in mice

May 12, 1998

IntraDose injectable gel shows promise in phase I/II

May 12, 1998

Resveratrol has a direct antiproliferative effect against breast cancer cells

May 12, 1998

New chemotherapeutic agent targets sst receptor-expressing cancers

May 11, 1998

Cell Therapeutics plans phase II trials for CT-2584

May 11, 1998

Magainin updates status of squalamine program

May 11, 1998

Myriad Genetics awarded fourth patent covering the BRCA1 gene

May 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.